Clinical Trials Browser

Interventional × Hematologic Neoplasms × gilteritinib × Clear all

NCT06001788 2025-12-03

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Phase 1 Recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Neoplasms by Histologic Type, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT06992934 2025-08-03

TARGETALLO

Phase NA Not yet recruiting

Other hematologic neoplasm

Hematologic Neoplasms